Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Pyridostigmine for the Treatment of Constipation in Parkinson Disease
Recruiting · NCT05603715 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pyridostigmine for the Treatment of Constipation in Parkinson Disease | Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, basal ganglia disorder, brain disorder, central nervous system disorder, constipation disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 2 | 2026-02-23 | NCT05603715 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Vermont Medical Center | 23 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Vermont Medical Center | Burlington | United States | 157 |